Clinical Trials for Stingray Therapeutics

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Stingray Therapeutics

Clinical Trials (2)

NCT06589440
Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)
PHASE2Recruiting
70 participants
Started: Nov 20, 2024 · Completed: Sep 30, 2027
1 condition1 sponsor5 locations
NCT06063681
A Study of SR-8541A (ENPPI Inhibitor) in Advanced/Metastatic Solid Tumors
PHASE1Recruiting
25 participants
Started: Oct 12, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor3 locations